Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 2
2013 7
2014 1
2015 2
2016 6
2017 4
2018 4
2019 6
2020 7
2021 8
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

50 results
Results by year
Filters applied: . Clear all
Page 1
The Molecular Mechanisms of Vitamin A Deficiency in Multiple Sclerosis.
Reza Dorosty-Motlagh A, Mohammadzadeh Honarvar N, Sedighiyan M, Abdolahi M. Reza Dorosty-Motlagh A, et al. Among authors: abdolahi m. J Mol Neurosci. 2016 Sep;60(1):82-90. doi: 10.1007/s12031-016-0781-0. Epub 2016 Jun 29. J Mol Neurosci. 2016. PMID: 27356515 Review.
Molecular mechanisms of omega-3 fatty acids in the migraine headache.
Soveyd N, Abdolahi M, Bitarafan S, Tafakhori A, Sarraf P, Togha M, Okhovat AA, Hatami M, Sedighiyan M, Djalali M, Mohammadzadeh Honarvar N. Soveyd N, et al. Among authors: abdolahi m. Iran J Neurol. 2017 Oct 7;16(4):210-217. Iran J Neurol. 2017. PMID: 29736227 Free PMC article. Review.
Necrotizing Sarcoid Granulomatosis with Pneumothorax.
Pourabdollah M, Saghebi SR, Abdolahi M, Rezaei MS. Pourabdollah M, et al. Among authors: abdolahi m. Case Rep Med. 2019 May 30;2019:4648720. doi: 10.1155/2019/4648720. eCollection 2019. Case Rep Med. 2019. PMID: 31275399 Free PMC article.
The Effect of Vitamin D3 Supplementation on Serum BDNF, Dopamine, and Serotonin in Children with Attention-Deficit/Hyperactivity Disorder.
Seyedi M, Gholami F, Samadi M, Djalali M, Effatpanah M, Yekaninejad MS, Hashemi R, Abdolahi M, Chamari M, Honarvar NM. Seyedi M, et al. Among authors: abdolahi m. CNS Neurol Disord Drug Targets. 2019;18(6):496-501. doi: 10.2174/1871527318666190703103709. CNS Neurol Disord Drug Targets. 2019. PMID: 31269890 Clinical Trial.
The Neuromodulatory Effects of ω-3 Fatty Acids and Nano-Curcumin on the COX-2/ iNOS Network in Migraines: A Clinical Trial Study from Gene Expression to Clinical Symptoms.
Abdolahi M, Jafarieh A, Sarraf P, Sedighiyan M, Yousefi A, Tafakhori A, Abdollahi H, Salehinia F, Djalali M. Abdolahi M, et al. Endocr Metab Immune Disord Drug Targets. 2019;19(6):874-884. doi: 10.2174/1871530319666190212170140. Endocr Metab Immune Disord Drug Targets. 2019. PMID: 30760195 Clinical Trial.
50 results